A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Clinical trial NCT06440824 · UNKNOWN

Trial details

NCT number: NCT06440824
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

CTIT-Chemotherapy Induced Thrombocytopenia

Start date: 2024-06-01
Primary completion: 2025-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.